127 related articles for article (PubMed ID: 17225465)
1. Effects of mizoribine on MHC-restricted exogenous antigen presentation in dendritic cells.
Song Y; Han S; Kim H; Kim K; Kwon J; Lee SJ; Ha NJ; Lee YH; Lee CK; Kim K
Arch Pharm Res; 2006 Dec; 29(12):1147-53. PubMed ID: 17225465
[TBL] [Abstract][Full Text] [Related]
2. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-colony stimulating factor enhances MHC-restricted presentation of exogenous antigen in dendritic cells.
Han S; Song Y; Lee YH; Lee YR; Lee CK; Cho K; Kim K
Cytokine; 2005 Dec; 32(5):187-93. PubMed ID: 16303313
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells.
Lee YR; Yang IH; Lee YH; Im SA; Song S; Li H; Han K; Kim K; Eo SK; Lee CK
Blood; 2005 May; 105(10):3951-5. PubMed ID: 15657176
[TBL] [Abstract][Full Text] [Related]
5. MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells.
Utsugi-Kobukai S; Fujimaki H; Hotta C; Nakazawa M; Minami M
Immunol Lett; 2003 Oct; 89(2-3):125-31. PubMed ID: 14556969
[TBL] [Abstract][Full Text] [Related]
6. Baccatin III, a synthetic precursor of taxol, enhances MHC-restricted antigen presentation in dendritic cells.
Lee YH; Lee YR; Kim KH; Im SA; Song S; Lee MK; Kim Y; Hong JT; Kim K; Lee CK
Int Immunopharmacol; 2011 Aug; 11(8):985-91. PubMed ID: 21354357
[TBL] [Abstract][Full Text] [Related]
7. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
[TBL] [Abstract][Full Text] [Related]
8. Corticosterone impairs MHC class I antigen presentation by dendritic cells via reduction of peptide generation.
Truckenmiller ME; Princiotta MF; Norbury CC; Bonneau RH
J Neuroimmunol; 2005 Mar; 160(1-2):48-60. PubMed ID: 15710457
[TBL] [Abstract][Full Text] [Related]
9. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
Herrera OB; Brett S; Lechler RI
Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
[TBL] [Abstract][Full Text] [Related]
10. Peptide-loaded dendritic cells prime and activate MHC-class I-restricted T cells more efficiently than protein-loaded cross-presenting DC.
Met O; Buus S; Claesson MH
Cell Immunol; 2003 Apr; 222(2):126-33. PubMed ID: 12826082
[TBL] [Abstract][Full Text] [Related]
11. [The influence of mycophenolate mofetil upon the maturation and allostimulatory activity of cultured dendritic cell progenitors and the effects of tolerance induction in allograft recipients].
Han CH; Li HF; Wang YX; Zhang M; Wang Y; Yin M; Min ZL; Zheng KL
Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1327-32. PubMed ID: 16029632
[TBL] [Abstract][Full Text] [Related]
12. Freezing and thawing of bone marrow-derived murine dendritic cells with subsequent retention of immunophenotype and of antigen processing and presentation characteristics.
Sai T; Milling SW; Mintz B
J Immunol Methods; 2002 Jun; 264(1-2):153-62. PubMed ID: 12191518
[TBL] [Abstract][Full Text] [Related]
13. Mizoribine--an inosine monophosphate dehydrogenase inhibitor--acts synergistically with cyclosporine A in prolonging survival of murine islet cell and heart transplants across major histocompatibility barrier.
Fukami N; Subramanian V; Angaswamy N; Liu W; Mohanakumar T; Hoshinaga K
Transpl Immunol; 2012 Mar; 26(2-3):140-5. PubMed ID: 22085688
[TBL] [Abstract][Full Text] [Related]
14. Lead effects on development and function of bone marrow-derived dendritic cells promote Th2 immune responses.
Gao D; Mondal TK; Lawrence DA
Toxicol Appl Pharmacol; 2007 Jul; 222(1):69-79. PubMed ID: 17512567
[TBL] [Abstract][Full Text] [Related]
15. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
Machy P; Serre K; Baillet M; Leserman L
J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
[TBL] [Abstract][Full Text] [Related]
16. Mizoribine and mycophenolate mofetil.
Ishikawa H
Curr Med Chem; 1999 Jul; 6(7):575-97. PubMed ID: 10390602
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin inhibitors block MHC-restricted antigen presentation in vivo.
Lee YH; Lee YR; Im SA; Park SI; Kim KH; Gerelchuluun T; Song S; Kim K; Lee CK
J Immunol; 2007 Nov; 179(9):5711-6. PubMed ID: 17947643
[TBL] [Abstract][Full Text] [Related]
18. The Vacuolar Pathway in Macrophages Plays a Major Role in Antigen Cross-Presentation Induced by the Pore-Forming Protein Sticholysin II Encapsulated Into Liposomes.
Cruz-Leal Y; Grubaugh D; Nogueira CV; Lopetegui-González I; Del Valle A; Escalona F; Laborde RJ; Alvarez C; Fernández LE; Starnbach MN; Higgins DE; Lanio ME
Front Immunol; 2018; 9():2473. PubMed ID: 30455685
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory mechanism of mizoribine on the antibody production of mouse B cells stimulated with lipopolysaccharide.
Kamada H; Itoh H; Shibata H; Koshio T; Hayashi A; Nakagami K
Jpn J Pharmacol; 1997 Aug; 74(4):323-30. PubMed ID: 9307328
[TBL] [Abstract][Full Text] [Related]
20. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
